Back

Buprenorphine Waiver Half and Half Training (9/8) Virtual

8:00am - September 8, 2021 thru 12:00pm - September 8, 2021 | Timezone: US/Eastern
Central East ATTC
Registration Deadline: September 8, 2021
Need more information?
Contact us at [email protected]

Historically, medication assisted treatment waiver training has been available for physicians, nurse practitioners, and physician assistants interested in seeking to apply for their waiver to prescribe buprenorphine in the treatment of opioid use disorders. To obtain the waiver to prescribe buprenorphine, providers were required to take eight hours of training. On April 27, 2021, HHS released New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder no longer requiring the completion of 8 hours waiver training course. However, in recognition that many practitioners will still want and need training on the clinical induction and management of Buprenorphine, PCSS-MAT, the Central East ATTC and DSAMH have partnered to bring this training. This training will provide information about these new practice guidelines as well as the clinical aspects of Buprenorphine prescribing. PCSS-MAT has a comprehensive library of materials (many are designated for AMA PRA Category 1 CreditTM) available at no cost created to give healthcare providers confidence in treating their patients more effectively. PCSS-MAT also has a no-cost clinical coaching/mentoring program to provide one-on-one clinical expertise for primary care providers. 

AAAP is the Data Sponsor for this waiver training. [email protected]

Registration for this series is through the Delaware Learning portal, which is open to all, although you must create an account.


Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry and Program of Addiction Research and Division of Substance Abuse and Mental Health. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this Other activity (one portion of this course is an independent online activity and another portion of this course is a live face-to-face educational exchange with a clinical expert trained to present this material) for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement:  American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192.  This program is approved for up to 8 Nursing Contact Hours.

PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits.  PAs should only claim credit commensurate with the extent of their participation. 


Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government